Manning & Napier Group, LLC Qiagen N.V. Transaction History

Manning & Napier Group, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 13, 2020	SELL	$33.17 - $41.6 $20.9 Million - $26.2 Million	-630,167 Closed	0 $0
Q4 2019 Jan 10, 2020	SELL	$25.41 - $43.1 $6.43 Million - $10.9 Million	-253,162 Reduced 28.66%	630,167 $21.3 Million
Q3 2019 Oct 10, 2019	SELL	$32.73 - $40.81 $8,247 - $10,284	-252 Reduced 0.03%	883,329 $29.1 Million
Q2 2019 Jul 24, 2019	BUY	$35.73 - $41.39 $952,311 - $1.1 Million	26,653 Added 3.11%	883,581 $35.8 Million
Q1 2019 Apr 10, 2019	SELL	$33.78 - $40.68 $4.59 Million - $5.52 Million	-135,808 Reduced 13.68%	856,928 $34.9 Million
Q4 2018 Jan 24, 2019	SELL	$32.65 - $37.95 $4.17 Million - $4.85 Million	-127,743 Reduced 11.4%	992,736 $34.2 Million
Q3 2018 Oct 10, 2018	SELL	$35.99 - $39.39 $1.2 Million - $1.31 Million	-33,342 Reduced 2.89%	1,120,479 $42.4 Million
Q2 2018 Jul 13, 2018	SELL	$31.23 - $37.47 $33.1 Million - $39.7 Million	-1,059,728 Reduced 47.87%	1,153,821 $41.7 Million
Q1 2018 May 01, 2018	SELL	$31.01 - $34.72 $7.58 Million - $8.49 Million	-244,551 Reduced 9.95%	2,213,549 $71.5 Million
Q4 2017 Feb 05, 2018	BUY	$30.68 - $35.37 $75.4 Million - $86.9 Million	2,458,100	2,458,100 $76 Million

6.37M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $10.5B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Manning & Napier Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Manning & Napier Group, LLC with notifications on news.